Navigation Links
Anesiva to Present at BioCentury's NewsMakers in the Biotech Industry Conference on September 6, 2007
Date:8/31/2007

SOUTH SAN FRANCISCO, Calif., Aug. 31 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today that John P. McLaughlin, the company's chief executive officer, will present at BioCentury's Newsmakers in the Biotech Industry Conference in New York City on September 6, 2007 at 10:30 a.m. EDT.

To access the live webcast or the subsequent archived recording, log on to http://www.anesiva.com, go to the Investors page, and click on Events. Please connect to Anesiva's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

About Anesiva and its Diverse Portfolio of Pain Products

Anesiva, Inc. is a late-stage biopharmaceutical company that seeks to be the leader in the development and commercialization of novel therapeutic treatments for pain. The company has one FDA-approved product, Zingo(TM), for the reduction of pain associated with peripheral venous access procedures in children three to 18 years of age. The second product in Anesiva's portfolio, Adlea(TM) (formerly 4975), has been shown to reduce pain after only a single administration for weeks to months in multiple settings in numerous mid-stage clinical trials for site-specific, acute and chronic, moderate-to-severe pain. Anesiva is based in South San Francisco, CA. For more information about Anesiva's leadership in the development of products for pain management, and an overview of the clinical challenges being addressed by its product candidates, go to http://www.anesiva.com.


'/>"/>
SOURCE Anesiva, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... , May 26, 2015 Pharmaco-Kinesis Corporation ... (NOCAB) recently convened at Shutters on the Beach in ... the development status of the Company,s innovative Metronomic Biofeedback ... to locally deliver chemotherapy over time to a target ... delivery capacity and biofeedback system in real-time.  ...
(Date:5/26/2015)... , 26. mája 2015 Kevin ... svojej rodiny prezidentom Barackovi Obamovi a Billovi Clintonovi ... so stratou Dr. Rongxiang Xu , otca ... Dr. Xu bol pionier, inovátor, ... jeho odhodlanie v oblasti vedy a príkladné vedenie ...
(Date:5/26/2015)... MENLO PARK, Calif. , May 26, 2015 /PRNewswire/ ... focused on the emerging field of regenerative medicine, today ... issued in June 2014 were exercised prior to their ... to the Company of $11.7 million. "We ... Pedro Lichtinger , President and CEO of Asterias. "This ...
(Date:5/26/2015)... , May 26, 2015 /PRNewswire/ - Fluorinov Pharma ... of Luke M. Beshar to its Board ... financial and pharmaceutical industry expertise as Fluorinov accelerates its ... the Fluorinov team, it is a pleasure to welcome ... a significant impact on the strategy, financial strength and ...
Breaking Biology Technology:Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 2Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 3Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 4Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 5Dr. Rongxiang Xu, O legende 2Asterias Biotherapeutics Receives $11.7 Million in Proceeds from Exercise of Warrants 2Asterias Biotherapeutics Receives $11.7 Million in Proceeds from Exercise of Warrants 3Luke M. Beshar Appointed to Fluorinov Pharma Board of Directors 2Luke M. Beshar Appointed to Fluorinov Pharma Board of Directors 3
... University today announced the public launch of the Tufts ...   The Institute is a university-wide, global ... diverse portfolio of drug discovery and development partnerships. ... by Tufts University School of Medicine and Tufts University,s ...
... Calif., Feb. 11, 2011 Abaxis, Inc. (Nasdaq: ... blood analysis instruments for the medical, research and veterinary ... Scandinavian Micro Biodevices APS, ("SMB"), a privately-held developer and ... SMB, based in Copenhagen, Denmark, has been ...
... 11, 2011 ImmunGene, Inc., a privately held drug ... that a profile of the company and its interferon ... in the February 7 issue of BioCentury , ... pharma and biotech industries. ( www.biocentury.com ) ...
Cached Biology Technology:Tufts Launches Institute for Biopharmaceutical Partnerships 2Tufts Launches Institute for Biopharmaceutical Partnerships 3Tufts Launches Institute for Biopharmaceutical Partnerships 4Abaxis Makes $2.8 Million Equity Investment in Scandinavian Micro Biodevices APS 2Abaxis Makes $2.8 Million Equity Investment in Scandinavian Micro Biodevices APS 3Abaxis Makes $2.8 Million Equity Investment in Scandinavian Micro Biodevices APS 4ImmunGene's Interferon Payload Technology Platform Featured in BioCentury Magazine 2
(Date:5/25/2015)... 25, 2015  Australia,s market for wearable technologies is ... saw the advent of several trials and prototypes. The ... is expected to ignite interest in wearables as well ... Australia . This in turn will spur greater ... new partnerships amongst vendors and distributors. ...
(Date:5/21/2015)... 2015 According to a ... (Hardware, Software, Services), by Applications (Surveillance (Airborne, Maritime, ... End-Users (Military & Defense & Commercial) - Global ... Market is expected to grow from $7252.0 Million ... a Compound Annual Growth Rate (CAGR) of 6.6%. ...
(Date:5/20/2015)... 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... owned subsidiary, 3D-ID LLC, a company engaged in biometric ... the biometrics technology portion of the recently awarded TIES ... Department of the Army. 3D-ID LLC has ... government, law enforcement and security agencies. ...
Breaking Biology News(10 mins):Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3
... in German . , EUMINAfab offers ... nanotechnologies for users from science and industry. Today, this ... Ten leading institutions from research and industry in eight ... high-tech installations along with the corresponding scientific and technological ...
... about how fat causes hypertension have been identified by researchers ... obese people and maybe some thin ones too ... best for them. Medical College of Georgia researchers ... mice at risk for hypertension by interfering with an endogenous ...
... of the world,s top cancer specialists will be in ... International Cancer Symposium organised by Queen,s University. The ... and Cancer Research (CCRCB) on Wednesday and Thursday, will ... and Europe, including those from Harvard Medical School in ...
Cached Biology News:Scientific pathways into the nanoworld 2Scientific pathways into the nanoworld 3New information about how fat increases blood pressure could help identify those at risk 2New information about how fat increases blood pressure could help identify those at risk 3International event brings world's top cancer doctors to Queen's 2International event brings world's top cancer doctors to Queen's 3
... of several isoprostanes produced from arachidonic acid during ... in the rat. 8-iso PGE2 inhibits U-46619 or ... and 5 µM, respectively. When infused into the ... of 4 mg/kg/min, 8-iso PGE2 decreases the GFR ...
DNA Polymerase I Large (Klenow) Fragment is a DNA polymerase that lacks the 5'Cut Site3' exodeoxyribonuclease activity of intact DNA Polymerase I but it contains the 3'Cut Site5' exodeoxyribonuclease...
... Centra-CL5R multi-purpose centrifuge offers both high-speed ... assortment of rotor options, making it ... applications., Maximum Versatility , High-speed ... angle rotors or high-volume (4 x 250mL) ...
Guanylate Kinase Purified Anti-Mouse, Anti-Rat clone 28, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
Biology Products: